Syndax Pharmaceuticals and Royalty Pharma Announce $350 Million Royalty Funding Agreement for Niktimvo™ Syndax Pharmaceuticals has entered into a substantial $350 million royalty funding agreement with Royalty Pharma, focused on the U.S.

www.linkedin.com/pulse/syndax...

Syndax Pharmaceuticals and Royalty Pharma Announce $350 Million Royalty Funding Agreement for Niktimvo™

#SyndaxPharma #RoyaltyPharma #Niktimvo #GVHD #BiotechFunding #Incyte #Biotechnology #Humanteconomy #Humantech